|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Effect of emergency contraception with levonorgestrel or mifepristone on |
| Marions L; Cekan SZ; Bygdeman M; Gemzell-Danielsson K |
| Contraception. 2004 May;69(5):373-377. |
| The mechanism of action of levonorgestrel (LNG) and mifepristone (MIF) in emergency contraception (EC), is still not |
| fully known. The purpose of this study was to evaluate the effect of preovulatory treatment with LNG and MIF on luteal |
| function in more detail. Two days prior to ovulation (day -2; assessed by ultrasound), we administered LNG (0.75 mg |
| twice, 12 h apart) or MIF (10 mg, single dose) to seven women in different cycles. Follicle development was followed |
| by ultrasound. Urinary estrone glucuronide (E1), pregnanediol glucuronide (P4) and luteinizing hormone (LH) were |
| analyzed by enzyme immunoassays daily starting with day -2 for the rest of the menstrual cycle, along with urinary |
| creatinine (C). The treatment caused either a delay or an inhibition of the LH peak in all subjects. A significant delay |
| in P4 levels and an initial suppression of E1 levels were also noted. The development of the leading follicle was |
| either arrested or continued without signs of rupture. This study indicates that, when used for EC, LNG or MIF |
| administered prior to ovulation acts through an impaired ovulatory process and luteal function. (PubHealth.info |
| Document ID: CONT1T 530-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Effect of emergency contraception with levonorgestrel or |
| mifepristone on ovarian function.", is(are) Marions L; Cekan SZ; Bygdeman M; Gemzell-Danielsson K. The source |
| of this article is "Contraception. 2004 May;69(5):373-377.". This article was published in 2004 in English language(s). |
| (PubHealth.info® Document ID: CONT1T 530-06. All rights reserved with PubHealth.info) PIN: 530 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |